Your browser is no longer supported. Please, upgrade your browser.
A Agilent Technologies, Inc. monthly Stock Chart
A [NYSE]
Agilent Technologies, Inc.
IndexS&P 500 P/E45.94 EPS (ttm)2.21 Insider Own0.30% Shs Outstand309.00M Perf Week-3.02%
Market Cap31.52B Forward P/E27.71 EPS next Y3.67 Insider Trans-14.86% Shs Float307.19M Perf Month1.44%
Income691.00M PEG4.89 EPS next Q0.93 Inst Own90.70% Short Float0.85% Perf Quarter5.97%
Sales5.22B P/S6.03 EPS this Y26.10% Inst Trans0.06% Short Ratio2.21 Perf Half Y32.61%
Book/sh16.12 P/B6.31 EPS next Y13.66% ROA7.30% Target Price103.64 Perf Year33.46%
Cash/sh4.38 P/C23.21 EPS next 5Y9.40% ROE14.30% 52W Range61.13 - 107.62 Perf YTD19.17%
Dividend0.72 P/FCF60.85 EPS past 5Y37.50% ROI15.20% 52W High-5.20% Beta1.04
Dividend %0.71% Quick Ratio1.90 Sales past 5Y5.00% Gross Margin53.30% 52W Low66.89% ATR2.19
Employees16300 Current Ratio2.50 Sales Q/Q-1.00% Oper. Margin15.30% RSI (14)45.18 Volatility2.18% 1.85%
OptionableYes Debt/Eq0.47 EPS Q/Q5.50% Profit Margin13.20% Rel Volume1.18 Prev Close101.66
ShortableYes LT Debt/Eq0.46 EarningsAug 18 AMC Payout30.80% Avg Volume1.19M Price102.02
Recom2.40 SMA20-2.32% SMA500.89% SMA20015.68% Volume1,403,966 Change0.35%
Sep-30-20Initiated Atlantic Equities Neutral $105
Aug-19-20Reiterated Wells Fargo Overweight $100 → $105
Aug-19-20Reiterated SVB Leerink Outperform $95 → $100
Aug-19-20Reiterated Stifel Hold $85 → $100
Aug-19-20Reiterated Robert W. Baird Outperform $87 → $104
Aug-19-20Reiterated Jefferies Buy $95 → $110
Aug-19-20Reiterated Citigroup Neutral $85 → $100
Aug-19-20Reiterated BofA Securities Neutral $99 → $103
Feb-24-20Downgrade Needham Buy → Hold
Jan-08-20Initiated Wells Fargo Overweight $100
Jan-07-20Initiated Citigroup Neutral $85
Nov-26-19Reiterated Needham Buy $92 → $85
Nov-15-19Initiated Stifel Hold
Oct-18-19Downgrade UBS Buy → Neutral $82
Jul-16-19Downgrade BofA/Merrill Buy → Neutral $76
Jul-15-19Downgrade Barclays Overweight → Equal Weight $86 → $78
Jun-11-19Initiated Piper Jaffray Overweight $83
May-30-19Initiated Wolfe Research Peer Perform
Mar-15-19Initiated UBS Buy $92
Feb-25-19Reiterated Needham Buy $77 → $88
Oct-29-20 03:00PM  
Oct-26-20 06:15PM  
Oct-23-20 06:17AM  
Oct-19-20 07:38AM  
Oct-15-20 08:00AM  
Oct-14-20 08:00AM  
Oct-08-20 10:32AM  
Oct-07-20 04:44PM  
Sep-30-20 09:41AM  
Sep-17-20 11:30AM  
08:00AM  
06:42AM  
Sep-16-20 04:05PM  
Sep-09-20 10:38AM  
Sep-03-20 03:30PM  
Sep-01-20 08:00AM  
Aug-31-20 12:57PM  
Aug-27-20 08:00AM  
Aug-19-20 10:18AM  
09:55AM  
06:53AM  
01:00AM  
Aug-18-20 05:25PM  
04:14PM  
04:05PM  
09:08AM  
08:00AM  
Aug-17-20 03:55PM  
09:00AM  
Aug-14-20 09:16PM  
Aug-13-20 01:16PM  
Aug-12-20 09:35AM  
06:49AM  
06:43AM  
Aug-11-20 12:30PM  
Aug-07-20 12:00PM  
Aug-04-20 05:53PM  
Jul-29-20 11:47AM  
Jul-27-20 11:00AM  
Jul-22-20 12:00PM  
12:00PM  
Jul-13-20 07:29AM  
Jul-09-20 09:24PM  
Jul-02-20 12:34PM  
Jun-28-20 11:32AM  
Jun-20-20 11:30AM  
Jun-15-20 09:36AM  
Jun-11-20 10:05AM  
Jun-10-20 10:25AM  
Jun-04-20 01:51PM  
08:53AM  
Jun-03-20 03:23AM  
Jun-02-20 08:14AM  
08:10AM  
Jun-01-20 04:30PM  
11:50AM  
09:41AM  
08:48AM  
08:00AM  
May-29-20 08:32PM  
May-28-20 12:12PM  
06:13AM  
May-27-20 11:00AM  
May-25-20 03:50AM  
May-23-20 10:43AM  
12:35AM  
May-22-20 09:36AM  
01:00AM  
May-21-20 05:25PM  
04:24PM  
04:05PM  
May-20-20 04:05PM  
12:53PM  
May-19-20 01:00PM  
May-18-20 10:39AM  
May-16-20 09:15AM  
May-15-20 08:15PM  
03:08PM  
May-14-20 12:30PM  
May-12-20 08:00AM  
May-07-20 01:27PM  
May-06-20 03:06PM  
May-05-20 08:09AM  
May-01-20 06:06AM  
Apr-30-20 10:44AM  
Apr-23-20 08:00AM  
Apr-22-20 08:00AM  
Apr-17-20 09:50AM  
Apr-15-20 09:37AM  
Apr-14-20 07:10PM  
08:00AM  
Apr-07-20 08:51AM  
Apr-06-20 08:39PM  
Apr-01-20 06:20AM  
Mar-31-20 08:00AM  
Mar-30-20 01:00PM  
08:00AM  
Mar-27-20 12:20PM  
08:44AM  
Mar-26-20 06:00AM  
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, and software as a service, as well as asset management and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. The company was founded in 1999 and is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grau DominiqueSenior Vice PresidentOct 09Option Exercise39.126,485253,693104,154Oct 13 02:32 PM
Grau DominiqueSenior Vice PresidentOct 09Sale105.006,485680,92597,669Oct 13 02:32 PM
Grau DominiqueSenior Vice PresidentAug 31Option Exercise39.126,485253,693104,154Sep 01 05:19 PM
Grau DominiqueSenior Vice PresidentAug 31Sale100.006,485648,50097,669Sep 01 05:19 PM
Gonsalves RodneyV.P., Corporate ControllerAug 25Option Exercise40.806,191252,59348,334Aug 27 12:15 PM
Gonsalves RodneyV.P., Corporate ControllerAug 25Sale98.176,191607,75242,143Aug 27 12:15 PM
McMullen Michael R.CEO and PresidentJul 30Option Exercise39.1272,7162,844,650575,215Aug 03 02:42 PM
McMullen Michael R.CEO and PresidentJul 30Sale95.7672,7166,963,575502,499Aug 03 02:42 PM
FIELDS HEIDIDirectorJun 04Sale91.0010,392945,6620Jun 08 02:08 PM
Gonsalves RodneyV.P., Corporate ControllerMay 27Option Exercise40.803,100126,48046,709May 28 07:04 PM
Gonsalves RodneyV.P., Corporate ControllerMay 27Sale85.304,566389,49942,143May 28 07:04 PM
Grau DominiqueSenior Vice PresidentMay 26Option Exercise26.199,033236,574106,702May 28 07:02 PM
Thaysen JacobSr. Vice PresidentMay 26Sale86.538,000692,240102,806May 28 07:03 PM
Grau DominiqueSenior Vice PresidentMay 26Sale86.569,033781,89697,669May 28 07:02 PM
McMullen Michael R.CEO and PresidentMay 15Sale82.506,917570,653504,642May 19 03:36 PM
McMullen Michael R.CEO and PresidentMay 08Sale80.0018,0181,441,440511,559May 11 01:42 PM
McMullen Michael R.CEO and PresidentApr 29Sale78.7213,6031,070,774529,245Apr 30 02:55 PM
McMullen Michael R.CEO and PresidentApr 27Sale76.208,814671,583542,848Apr 28 04:58 PM
Doak MarkSr. Vice PresidentMar 03Sale83.813,494292,832135,678Mar 04 02:09 PM
Doak MarkSr. Vice PresidentMar 02Sale82.002,867235,094139,172Mar 03 01:48 PM
Gonsalves RodneyV.P., Corporate ControllerFeb 25Sale80.021,00080,02443,421Feb 27 01:58 PM
Grau DominiqueSenior Vice PresidentJan 17Option Exercise26.199,033236,574106,530Jan 22 11:27 AM
Grau DominiqueSenior Vice PresidentJan 17Sale90.009,033812,97097,497Jan 22 11:27 AM
Tang MichaelSVP, General Counsel, and Sec.Jan 10Sale87.725,000438,60067,167Jan 14 12:03 PM
Tang MichaelSVP, General Counsel, and Sec.Dec 30Sale85.345,000426,70072,167Jan 02 02:40 PM
Tang MichaelSVP, General Counsel, and Sec.Dec 20Option Exercise40.803,364137,25180,531Dec 20 04:38 PM
Tang MichaelSVP, General Counsel, and Sec.Dec 20Sale85.003,364285,94077,167Dec 20 04:38 PM
Grau DominiqueSenior Vice PresidentDec 12Option Exercise27.197,712209,689105,209Dec 13 07:06 PM
Doak MarkSr. Vice PresidentDec 12Sale84.508,016677,386142,017Dec 13 07:05 PM
Grau DominiqueSenior Vice PresidentDec 12Sale84.007,712647,80897,497Dec 13 07:06 PM
Grau DominiqueSenior Vice PresidentDec 11Sale82.8515,0001,242,69097,498Dec 12 08:37 PM
McMullen Michael R.CEO and PresidentDec 10Option Exercise26.1924,636645,217576,298Dec 13 07:08 PM
Tang MichaelSVP, General Counsel, and Sec.Dec 10Option Exercise40.803,364137,25180,532Dec 12 08:36 PM
Tang MichaelSVP, General Counsel, and Sec.Dec 10Sale82.903,364278,87677,168Dec 12 08:36 PM
McMullen Michael R.CEO and PresidentDec 10Sale82.9024,6362,042,324551,662Dec 13 07:08 PM
McMullen Michael R.CEO and PresidentNov 25Option Exercise26.1924,636645,217576,299Dec 13 07:08 PM
McMullen Michael R.CEO and PresidentNov 25Sale80.0024,6361,970,880551,663Dec 13 07:08 PM
Doak MarkSr. Vice PresidentNov 15Option Exercise21.53612995,912Nov 19 08:04 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.